Sarepta Therapeutics (SRPT) EBT (2010 - 2026)
Sarepta Therapeutics' quarterly EBT came in at $343.2 million in Q1 2026, up 189.48% year-on-year from $118.5 million in Q1 2025, and up 223.31% quarter-over-quarter from -$278.3 million in Q4 2025.
Sarepta Therapeutics has reported EBT for 17 years, with the latest figure at $343.2 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 189.48% year-over-year to $343.2 million; the trailing twelve-month figure through Mar 2026 stood at $24.5 million (up 109.55% YoY), and the FY2025 full-year result was -$702.2 million, down 516.34% from the prior year.
- EBT for Q1 2026 stood at $343.2 million, up from -$278.3 million in the prior quarter.
- The five-year high for EBT was $343.2 million in Q1 2026, with the low at -$512.7 million in Q1 2023.
- Average EBT over 5 years is -$42.5 million, with a median of -$14.6 million recorded in 2023.
- Peak annual rise in EBT reached 1031.6% in 2025, while the deepest fall reached 1025.3% in 2025.
- Tracing SRPT's EBT over 5 years: stood at $337.3 million in 2022, then declined by 17.27% to $279.0 million in 2023, then slumped by 71.46% to $79.6 million in 2024, then slumped by 449.46% to -$278.3 million in 2025, then soared by 223.31% to $343.2 million in 2026.
- The last three EBT figures came in at $343.2 million (Q1 2026), -$278.3 million (Q4 2025), and -$194.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 343.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343.17 Mn |
| Dec 31, 2025 | -278.30 Mn |
| Sep 30, 2025 | -194.05 Mn |
| Jun 30, 2025 | 153.64 Mn |
| Mar 31, 2025 | -383.52 Mn |
| Dec 31, 2024 | 79.64 Mn |
| Sep 30, 2024 | 34.01 Mn |
| Jun 30, 2024 | 13.58 Mn |
| Mar 31, 2024 | 41.45 Mn |
| Dec 31, 2023 | 279.03 Mn |
| Sep 30, 2023 | -33.17 Mn |
| Jun 30, 2023 | -14.59 Mn |
| Mar 31, 2023 | -512.71 Mn |
| Dec 31, 2022 | 337.27 Mn |
| Sep 30, 2022 | -256.42 Mn |
| Jun 30, 2022 | -228.09 Mn |
| Mar 31, 2022 | -104.15 Mn |
| Dec 31, 2021 | -74.26 Mn |
| Sep 30, 2021 | -47.91 Mn |
| Jun 30, 2021 | -81.76 Mn |
| Mar 31, 2021 | -167.39 Mn |
| Dec 31, 2020 | -188.49 Mn |
| Sep 30, 2020 | -196.40 Mn |
| Jun 30, 2020 | -150.80 Mn |
| Mar 31, 2020 | -17.38 Mn |
| Dec 31, 2019 | -234.99 Mn |
| Sep 30, 2019 | -126.10 Mn |
| Jun 30, 2019 | -276.23 Mn |
| Mar 31, 2019 | -76.56 Mn |
| Dec 31, 2018 | -141.67 Mn |
| Sep 30, 2018 | -77.07 Mn |
| Jun 30, 2018 | -108.65 Mn |
| Mar 31, 2018 | -35.22 Mn |
| Dec 31, 2017 | -25.84 Mn |
| Sep 30, 2017 | -45.72 Mn |
| Jun 30, 2017 | -63.16 Mn |
| Mar 31, 2017 | 86.09 Mn |
| Dec 31, 2016 | -88.45 Mn |
| Sep 30, 2016 | -56.74 Mn |
| Jun 30, 2016 | -62.30 Mn |
| Mar 31, 2016 | -59.77 Mn |
| Dec 31, 2015 | -64.45 Mn |
| Sep 30, 2015 | -51.76 Mn |
| Jun 30, 2015 | -42.11 Mn |
| Mar 31, 2015 | -61.86 Mn |
| Dec 31, 2014 | -44.72 Mn |
| Sep 30, 2014 | -33.68 Mn |
| Jun 30, 2014 | -30.27 Mn |
| Mar 31, 2014 | -25.12 Mn |
| Dec 31, 2013 | -32.85 Mn |
| Sep 30, 2013 | -24.87 Mn |
| Jun 30, 2013 | -17.11 Mn |
| Mar 31, 2013 | -15.18 Mn |
| Dec 31, 2012 | -10.28 Mn |
| Sep 30, 2012 | -6.84 Mn |
| Jun 30, 2012 | -5.45 Mn |
| Mar 31, 2012 | -6.78 Mn |
| Dec 31, 2011 | -8.85 Mn |
| Sep 30, 2011 | -11.07 Mn |
| Jun 30, 2011 | -9.97 Mn |
| Mar 31, 2011 | -5.44 Mn |
| Dec 31, 2010 | -1.65 Mn |
| Sep 30, 2010 | -3.72 Mn |
| Jun 30, 2010 | -7.62 Mn |